Equities research analysts forecast that MedEquities Realty Trust Inc. (NYSE:MRT) will post sales of $15.42 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for MedEquities Realty Trust’s earnings. The highest sales estimate is $15.80 million and the lowest is $15.17 million. MedEquities Realty Trust posted sales of $13.85 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 11.3%. The business is expected to announce its next quarterly earnings report after the market closes on Tuesday, November 7th.

According to Zacks, analysts expect that MedEquities Realty Trust will report full-year sales of $15.42 million for the current financial year, with estimates ranging from $59.26 million to $62.00 million. For the next year, analysts forecast that the company will post sales of $76.54 million per share, with estimates ranging from $75.66 million to $78.30 million. Zacks’ sales averages are a mean average based on a survey of sell-side research firms that cover MedEquities Realty Trust.

MRT has been the topic of several recent analyst reports. KeyCorp restated a “buy” rating and issued a $13.00 price objective on shares of MedEquities Realty Trust in a report on Tuesday, September 26th. Capital One Financial Corporation reiterated an “equal weight” rating on shares of MedEquities Realty Trust in a report on Sunday, October 22nd. Zacks Investment Research upgraded shares of MedEquities Realty Trust from a “sell” rating to a “hold” rating in a report on Wednesday, July 19th. Finally, Cantor Fitzgerald began coverage on shares of MedEquities Realty Trust in a report on Thursday, August 31st. They set an “overweight” rating and a $14.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $13.00.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 29th. Shareholders of record on Wednesday, November 15th will be given a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 7.18%. The ex-dividend date of this dividend is Tuesday, November 14th. MedEquities Realty Trust’s dividend payout ratio is presently 240.00%.

Several large investors have recently made changes to their positions in MRT. Morgan Stanley increased its position in shares of MedEquities Realty Trust by 99.7% in the 1st quarter. Morgan Stanley now owns 1,902,876 shares of the financial services provider’s stock valued at $21,331,000 after purchasing an additional 949,892 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of MedEquities Realty Trust by 59.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,191,484 shares of the financial services provider’s stock valued at $24,567,000 after purchasing an additional 813,540 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in shares of MedEquities Realty Trust by 372.8% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 320,531 shares of the financial services provider’s stock valued at $3,594,000 after purchasing an additional 252,739 shares during the last quarter. Boston Partners increased its position in shares of MedEquities Realty Trust by 18.5% in the 2nd quarter. Boston Partners now owns 1,423,929 shares of the financial services provider’s stock valued at $17,970,000 after purchasing an additional 221,911 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its position in shares of MedEquities Realty Trust by 43.0% in the 2nd quarter. Russell Investments Group Ltd. now owns 642,623 shares of the financial services provider’s stock valued at $8,112,000 after purchasing an additional 193,182 shares during the last quarter. 93.05% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/03/15-42-million-in-sales-expected-for-medequities-realty-trust-inc-mrt-this-quarter.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.